Leaflet DIENILLE film-coated tablets

Product code:
W56004001
Quantity:
21
Indicated for:
contraception
Route of administration:
oral
Substance:
dienogest + ethinylestradiol (progestogen + estrogen)
ATC
G03FA15 — Genito urinary system and sex hormones | Progestogens and estrogens in combination | Progestogens and estrogens, fixed combinations

Precautions:

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

The combination of dienogest and ethinylestradiol is used as an oral contraceptive to prevent pregnancy. Dienogest is a progestin, and ethinylestradiol is an estrogen, both working to inhibit ovulation and alter the uterine lining.

The medication is taken orally, usually once daily at the same time, following a 21- or 28-day cycle. It is important to adhere to the administration schedule to ensure contraceptive effectiveness.

Side effects may include nausea, headaches, breast tenderness, or mood changes. In rare cases, severe reactions such as venous thromboembolism may occur.

This combination is not recommended for pregnant women, breastfeeding mothers, or patients with a history of thrombosis, severe liver disease, or hypersensitivity to any of the components.

General data about DIENILLE

Substance:
dienogest + ethinylestradiol
Date of latest medicines list:
01-10-2015
Product code:
W56004001
Pharmaceutical form:
film-coated tablets
Quantity:
21
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.